Chemotherapy of AIDS--related Kaposi's sarcoma (Q41175512)

27 September 2017

1 reference

title

Chemotherapy of AIDS--related Kaposi's sarcoma (English)

1 reference

27 September 2017

1 reference

Lee FC

1

1 reference

PubMed ID

8880196

27 September 2017

Mitsuyasu RT

series ordinal

2

1 reference

27 September 2017

1 October 1996

1 reference

Hematology / Oncology Clinics of North America

27 September 2017

1 reference

27 September 2017

10

1 reference

27 September 2017

5

1 reference

27 September 2017

1051-1068

1 reference

Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Liposomal encapsulation: making old and new drugs do new tricks

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

AIDS-associated mucocutaneous Kaposiʼs sarcoma treated with bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of oral Kaposi sarcoma with intralesional vinblastine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Pulmonary Kaposi's sarcoma: clinical findings and results of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of the acquired immune deficiency syndrome—related Kaposi's sarcoma with bleomycin as a single agent

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of oral Kaposi's sarcoma with a sclerosing agent in AIDS patients. A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Lack of vesicant injury following extravasation of liposomal doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Improved survival for patients with AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Clinical aspects of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of Kaposi's sarcoma. Current guidelines and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of cutaneous Kaposi's sarcoma with intralesional vincristine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of Kaposi's sarcoma by combination of actinomycin-D, vincristine and imidazole carboxamide (nsc-45388): results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Phase II study of teniposide in patients with AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Photodynamic therapy for treatment of AIDS-related oral Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Kaposi's sarcoma.Management with vincaleucoblastine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Chemotherapy for patients with pulmonary Kaposi's sarcoma: benefit of filgrastim (G-CSF) in supporting dose administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Iontophoresis of vinblastine into normal skin and for treatment of Kaposi's sarcoma in human immunodeficiency virus-positive patients. The Military Medical Consortium for Applied Retroviral Research

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma: clinical, histological and cell biological evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Malignant tumours in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment of Kaposi's sarcoma with a combination of actinomycin D and vincristine. Results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Treatment strategies for epidemic Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

Failure of isotretinoin in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970384-1

7 January 2021

10.1016/S0889-8588(05)70384-1

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

8880196